Targeting Non-Oncogene Addiction for Cancer Therapy

Targeting Non-Oncogene Addiction for Cancer Therapy

While Next-Generation Sequencing (NGS) and technological advances have been useful in identifying genetic profiles of tumorigenesis, novel target proteins and various clinical biomarkers, cancer continues to be a major global health threat. DNA replication, DNA damage response (DDR) and repair, and...

Full description

Bibliographic Details
Main Authors:	Hae Ryung Chang, Eunyoung Jung, Soobin Cho, Young-Jun Jeon, Yonghwan Kim
Format:	Article
Language:	English
Published:	MDPI AG 2021-01-01
Series:	Biomolecules
Subjects:	non-oncogene addiction DNA damage response DNA repair cancer therapy
Online Access:	https://www.mdpi.com/2218-273X/11/2/129

Similar Items

MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies
by: Seyed Esmaeil Ahmadi, et al.
Published: (2021-08-01)

Targeting Non-Oncogene Addiction: Focus on Thyroid Cancer
by: Maria Chiara Anania, et al.
Published: (2020-01-01)

A view on EGFR-targeted therapies from the oncogene-addiction perspective
by: Rolando ePerez, et al.
Published: (2013-04-01)

In Vivo Targeting Replication Protein A for Cancer Therapy
by: Pamela S. VanderVere-Carozza, et al.
Published: (2022-02-01)

Targeting the DNA Damage Response for Cancer Therapy
by: Ruoxi Wang, et al.
Published: (2023-11-01)

Is Immunotherapy Beneficial in Patients with Oncogene-Addicted Non-Small Cell Lung Cancers? A Narrative Review
by: David John McMahon, et al.
Published: (2024-01-01)

The multifaceted world of the DNA damage response
by: Antonio ePorro
Published: (2016-05-01)

Oncogenic viruses and their role in tumor formation
by: Ćupić Maja, et al.
Published: (2005-01-01)

DNA Damage Response in Cancer Therapy and Resistance: Challenges and Opportunities
by: Dana Jurkovicova, et al.
Published: (2022-11-01)

OB-Folds and Genome Maintenance: Targeting Protein–DNA Interactions for Cancer Therapy
by: Sui Par, et al.
Published: (2021-07-01)

DNA repair and cancer : from bench to clinic /
by: Wilson, David M., 1967- 545425, et al.
Published: (2013)

Oncogene-Addicted Non-Small-Cell Lung Cancer: Treatment Opportunities and Future Perspectives
by: Miriam Grazia Ferrara, et al.
Published: (2020-05-01)

Tolerance to paternal genotoxic damage promotes survival during embryo development in zebrafish (Danio rerio)
by: Cristina Fernández-Díez, et al.
Published: (2018-05-01)

Biological Adaptations of Tumor Cells to Radiation Therapy
by: Angeles Carlos-Reyes, et al.
Published: (2021-11-01)

Understanding DNA Damage Response and DNA Repair in Multiple Myeloma
by: Cole Petrilla, et al.
Published: (2023-08-01)

The DNA Damage Response in Fully Grown Mammalian Oocytes
by: Alexandros Pailas, et al.
Published: (2022-02-01)

Chemotherapeutic compounds targeting the DNA double-strand break repair pathways: the good, the bad and the promising
by: Christian Robert Jekimovs, et al.
Published: (2014-04-01)

Rethinking glutamine metabolism and the regulation of glutamine addiction by oncogenes in cancer
by: Rui Ni, et al.
Published: (2023-03-01)

Targeting Replication Stress Response Pathways to Enhance Genotoxic Chemo- and Radiotherapy
by: Jac A. Nickoloff
Published: (2022-07-01)

DNA damage checkpoint and repair: From the budding yeast Saccharomyces cerevisiae to the pathogenic fungus Candida albicans
by: Shuangyan Yao, et al.
Published: (2021-01-01)

The role of TIRR in DNA damage and repair
by: Ketley, R
Published: (2022)

Autophagy Roles in Genome Maintenance
by: Susanna Ambrosio, et al.
Published: (2020-07-01)

DNA damage response inhibition‐based combination therapies in cancer treatment: Recent advances and future directions
by: Tianen Chen, et al.
Published: (2022-03-01)

Krüppel-Like Factor 6 Is Required for Oxidative and Oncogene-Induced Cellular Senescence
by: Maria Eugenia Sabatino, et al.
Published: (2019-11-01)

Interplay between Cellular Metabolism and the DNA Damage Response in Cancer
by: Amandine Moretton, et al.
Published: (2020-07-01)

DNA Damage-Inducing Anticancer Therapies: From Global to Precision Damage
by: Thom G. A. Reuvers, et al.
Published: (2020-07-01)

The Influence of Oncogenic RAS on Chemotherapy and Radiotherapy Resistance Through DNA Repair Pathways
by: Rodrigo E. Cáceres-Gutiérrez, et al.
Published: (2022-03-01)

Targeting the rewired DNA damage response in cancer therapy
by: Marcel eVan Vugt, et al.
Published: (2015-12-01)

Metal nanoparticles for cancer therapy: Precision targeting of DNA damage
by: Qian Chen, et al.
Published: (2024-03-01)

Real estate in the DNA damage response: Ubiquitin and SUMO ligases home in on DNA double-strand breaks
by: Nico P. Dantuma, et al.
Published: (2016-04-01)

DNA damage response and repair in perspective: Aedes aegypti, Drosophila melanogaster and Homo sapiens
by: Maria Beatriz S. Mota, et al.
Published: (2019-11-01)

Investigating break induced replication and template switching in fission yeast
by: Laksir, Y
Published: (2022)

Cellular and biochemical characterisation of ERCC6L2
by: Armstrong, L
Published: (2021)

Mutant huntingtin impairs PNKP and ATXN3, disrupting DNA repair and transcription
by: Rui Gao, et al.
Published: (2019-04-01)

Persistent DNA damage triggers activation of the integrated stress response to promote cell survival under nutrient restriction
by: Elena Clementi, et al.
Published: (2020-03-01)

Importance of finding the bona fide target of the Fanconi anemia pathway
by: Wataru Sakai, et al.
Published: (2019-03-01)

The discovery of AVIL as a bona fide oncogene in glioblastoma
by: Zhongqiu Xie, et al.
Published: (2020-11-01)

Small molecules, inhibitors of DNA-PK, targeting DNA repair and beyond
by: David eDavidson, et al.
Published: (2013-01-01)

Adeno-Associated Virus Monoinfection Induces a DNA Damage Response and DNA Repair That Contributes to Viral DNA Replication
by: Kang Ning, et al.
Published: (2023-02-01)

DNA-PKcs: A Multi-Faceted Player in DNA Damage Response
by: Xiaoqiao Yue, et al.
Published: (2020-12-01)